nach oben

Translational Stroke Research

Erschienen in:

01.09.2011 | Review

Hyperbaric Oxygen for Cerebral Vasospasm and Brain Injury Following Subarachnoid Hemorrhage

verfasst von: Robert P. Ostrowski, John H. Zhang

Erschienen in: Translational Stroke Research | Ausgabe 3/2011

Einloggen, um Zugang zu erhalten

Abstract

The impact of acute brain injury and delayed neurological deficits due to cerebral vasospasm (CVS) are major determinants of outcomes after subarachnoid hemorrhage (SAH). Although hyperbaric oxygen (HBO) had been used to treat patients with SAH, the supporting evidence and underlying mechanisms have not been systematically reviewed. In the present paper, the overview of studies of HBO for cerebral vasospasm is followed by a discussion of HBO molecular mechanisms involved in the protection against SAH-induced brain injury and even, as hypothesized, in attenuating vascular spasm alone. Faced with the paucity of information as to what degree HBO is capable of antagonizing vasospasm after SAH, the authors postulate that the major beneficial effects of HBO in SAH include a reduction of acute brain injury and combating brain damage caused by CVS. Consequently, authors reviewed the effects of HBO on SAH-induced hypoxic signaling and other mechanisms of neurovascular injury. Moreover, authors hypothesize that HBO administered after SAH may “precondition” the brain against the detrimental sequelae of vasospasm. In conclusion, the existing evidence speaks in favor of administering HBO in both acute and delayed phase after SAH; however, further studies are needed to understand the underlying mechanisms and to establish the optimal regimen of treatment.

Keyrouz SG, Diringer MN. Clinical review: prevention and therapy of vasospasm in subarachnoid hemorrhage. Crit Care. 2007;11(4):220.PubMedCrossRef

Macdonald RL, Pluta RM, Zhang JH. Cerebral vasospasm after subarachnoid hemorrhage: the emerging revolution. Nat Clin Pract Neurol. 2007;3(5):256–63.PubMedCrossRef

Macdonald RL, Kassell NF, Mayer S, Ruefenacht D, Schmiedek P, Weidauer S, et al. Clazosentan to overcome neurological ischemia and infarction occurring after subarachnoid hemorrhage (CONSCIOUS-1): randomized, double-blind, placebo-controlled phase 2 dose-finding trial. Stroke. 2008;39(11):3015–21.PubMedCrossRef

Vajkoczy P, Meyer B, Weidauer S, Raabe A, Thome C, Ringel F, et al. Clazosentan (AXV-034343), a selective endothelin A receptor antagonist, in the prevention of cerebral vasospasm following severe aneurysmal subarachnoid hemorrhage: results of a randomized, double-blind, placebo-controlled, multicenter phase IIa study. J Neurosurg. 2005;103(1):9–17.PubMedCrossRef

Hansen-Schwartz J, Vajkoczy P, Macdonald RL, Pluta RM, Zhang JH. Cerebral vasospasm: looking beyond vasoconstriction. Trends Pharmacol Sci. 2007;28(6):252–25.PubMedCrossRef

Ostrowski RP, Colohan AR, Zhang JH. Molecular mechanisms of early brain injury after subarachnoid hemorrhage. Neurol Res. 2006;28(4):399–414.PubMedCrossRef

Kusaka G, Ishikawa M, Nanda A, Granger DN, Zhang JH. Signaling pathways for early brain injury after subarachnoid hemorrhage. J Cereb Blood Flow Metab. 2004;24(8):916–25.PubMedCrossRef

Stuart RM, Helbok R, Kurtz P, Schmidt M, Fernandez L, Lee K et al. High-dose intra-arterial verapamil for the treatment of cerebral vasospasm after subarachnoid hemorrhage: prolonged effects on hemodynamic parameters and brain metabolism. Neurosurgery. 2011 (in press).

Zubkov AY, Rabinstein AA. Medical management of cerebral vasospasm: present and future. Neurol Res. 2009;31(6):626–31.PubMedCrossRef

10.

Dankbaar JW, Slooter AJ, Rinkel GJ, Schaaf IC. Effect of different components of triple-H therapy on cerebral perfusion in patients with aneurysmal subarachnoid haemorrhage: a systematic review. Crit Care. 2010;14(1):R23.PubMedCrossRef

11.

Pluta RM, Hansen-Schwartz J, Dreier J, Vajkoczy P, Macdonald RL, Nishizawa S, et al. Cerebral vasospasm following subarachnoid hemorrhage: time for a new world of thought. Neurol Res. 2009;31(2):151–8.PubMedCrossRef

12.

Kasuya H. Clinical trial of nicardipine prolonged-release implants for preventing cerebral vasospasm: multicenter cooperative study in Tokyo. Acta Neurochir Suppl. 2011;110(2):165–7.PubMedCrossRef

13.

Ostrowski RP, Colohan AR, Zhang JH. Mechanisms of hyperbaric oxygen-induced neuroprotection in a rat model of subarachnoid hemorrhage. J Cereb Blood Flow Metab. 2005;25(5):554–71.PubMedCrossRef

14.

Kohshi K, Yokota A, Konda N, Kinoshita Y, Kajiwara H. Intracranial pressure responses during hyperbaric oxygen therapy. Neurol Med Chir (Tokyo). 1991;31(9):575–81.CrossRef

15.

Kohshi K, Yokota A, Konda N, Munaka M, Yasukouchi H. Hyperbaric oxygen therapy adjunctive to mild hypertensive hypervolemia for symptomatic vasospasm. Neurol Med Chir (Tokyo). 1993;33(2):92–9.CrossRef

16.

Isakov I, Pravdenkova SV, Shchelkovskii VN. [Hyperbaric oxygenation in ruptured cerebral aneurysms during the postoperative period]. Zh Vopr Neirokhir Im NN Burdenko. 1985;(3):17–21.

17.

Levina OA, Romasenko MV, Krylov V. Therapeutic effects of hyperbaric oxygenation (HBO) on acute cerebral ischemia in patients after intracranial aneurysms clipping. Eur J Underw Hyperb Med. 2002;3:83.

18.

Ohta H, Suzuki E, Hinuma Y, Kawamura S, Nemoto M, Hadeishi H. Effects of hyperoxia, glycerol and ventricular drainage on ICP and CBF in patients with increased ICP due to CSF circulatory-absorbance disturbance. No To Shinkei. 1987;39(3):273–9.PubMed

19.

Kawamura S, Ohta H, Yasui N, Nemoto M, Hinuma Y, Suzuki E. Effects of hyperbaric oxygenation in patients with subarachnoid hemorrhage. J Hyperb Med. 1988;3:243–56.

20.

Ugriumov VM, Elinskii MP, Rafikov AM, Kesaev SA. [Hyperbaric oxygenation in the complex treatment of patients with aneurysms of the cerebral vessels]. Zh Vopr Neirokhir Im NN Burdenko. 1980;(4):49–54.

21.

Kitaoka K, Nakagawa Y, Abe H, Satoh M, Iwakuma T. Hyperbaric oxygenation for the mental conditions following surgery of aneurysm of the anterior communicating artery. Hokkaido Igaku Zasshi. 1983;58(2):154–61.PubMed

22.

Takata K, Sheng H, Borel CO, Laskowitz DT, Warner DS, Lombard FW. Simvastatin treatment duration and cognitive preservation in experimental subarachnoid hemorrhage. J Neurosurg Anesthesiol. 2009;21(4):326–33.PubMedCrossRef

23.

Sen J, Belli A, Albon H, Morgan L, Petzold A, Kitchen N. Triple-H therapy in the management of aneurysmal subarachnoid haemorrhage. Lancet Neurol. 2003;2(10):614–21.PubMedCrossRef

24.

Walid SM, Zaytseva NV. Quadruple H therapy for vasospasm. Ann Indian Acad Neurol. 2009;12:22–4.PubMed

25.

Mchedlishvili G, Varazashvili M, Mamaladze A, Momtselidze N. Blood flow structuring and its alterations in capillaries of the cerebral cortex. Microvasc Res. 1997;53(3):201–10.PubMedCrossRef

26.

Dhar R, Zazulia AR, Videen TO, Zipfel GJ, Derdeyn CP, Diringer MN. Red blood cell transfusion increases cerebral oxygen delivery in anemic patients with subarachnoid hemorrhage. Stroke. 2009;40(9):3039–44.PubMedCrossRef

27.

Kocaogullar Y, Ustun ME, Avci E, Karabacakoglu A, Fossett D. The role of hyperbaric oxygen in the management of subarachnoid hemorrhage. Intensive Care Med. 2004;30(1):141–6.PubMedCrossRef

28.

Imperatore F, Cuzzocrea S, Luongo C, Liguori G, Scafuro A, De Angelis A, et al. Hyperbaric oxygen therapy prevents vascular derangement during zymosan-induced multiple-organ-failure syndrome. Intensive Care Med. 2004;30(6):1175–81.PubMedCrossRef

29.

Huang ZX, Kang ZM, Gu GJ, Peng GN, Yun L, Tao HY, et al. Therapeutic effects of hyperbaric oxygen in a rat model of endothelin-1-induced focal cerebral ischemia. Brain Res. 2007;1153:204–13.PubMedCrossRef

30.

Sharkey J, Butcher SP, Kelly JS. Endothelin-1 induced middle cerebral artery occlusion: pathological consequences and neuroprotective effects of MK801. J Auton Nerv Syst. 1994;49(Suppl):S177–85.PubMedCrossRef

31.

Gaetani P, Baena R, Grignani G, Spanu G, Pacchiarini L, Paoletti P. Endothelin and aneurysmal subarachnoid haemorrhage: a study of subarachnoid cisternal cerebrospinal fluid. J Neurol Neurosurg Psychiatry. 1994;57(1):66–72.PubMedCrossRef

32.

Hansen-Schwartz J, Ansar S, Edvinsson L. Cerebral vasoconstriction after subarachnoid hemorrhage—role of changes in vascular receptor phenotype. Front Biosci. 2008;13:2160–4.PubMedCrossRef

33.

Hansen-Schwartz J, Hoel NL, Zhou M, Xu CB, Svendgaard NA, Edvinsson L. Subarachnoid hemorrhage enhances endothelin receptor expression and function in rat cerebral arteries. Neurosurgery. 2003;52(5):1188–94.PubMedCrossRef

34.

Edvinsson L. Cerebrovascular endothelin receptor upregulation in cerebral ischemia. Curr Vasc Pharmacol. 2009;7(1):26–33.PubMedCrossRef

35.

Rothoerl RD, Ringel F. Molecular mechanisms of cerebral vasospasm following aneurysmal SAH. Neurol Res. 2007;29(7):636–42.PubMedCrossRef

36.

Hirata Y, Yoshimi H, Takaichi S, Yanagisawa M, Masaki T. Binding and receptor down-regulation of a novel vasoconstrictor endothelin in cultured rat vascular smooth muscle cells. FEBS Lett. 1988;239(1):13–7.PubMedCrossRef

37.

Lan C, Das D, Wloskowicz A, Vollrath B. Endothelin-1 modulates hemoglobin-mediated signaling in cerebrovascular smooth muscle via RhoA/Rho kinase and protein kinase C. Am J Physiol Heart Circ Physiol. 2004;286(1):H165–73.PubMedCrossRef

38.

Miao L, Dai Y, Zhang J. Mechanism of RhoA/Rho kinase activation in endothelin-1-induced contraction in rabbit basilar artery. Am J Physiol Heart Circ Physiol. 2002;283(3):H983–9.PubMed

39.

Zhou C, Li Y, Nanda A, Zhang JH. HBO suppresses Nogo-A, Ng-R, or RhoA expression in the cerebral cortex after global ischemia. Biochem Biophys Res Commun. 2003;309(2):368–76.PubMedCrossRef

40.

Sheth MV, Goodman BE, Friese JL, Eyster KM. Protein kinase and phosphatase activity in the lungs of normoxic versus hyperoxic rats. Exp Lung Res. 1997;23(6):475–94.PubMedCrossRef

41.

Wang X, Wang Y, Kim HP, Choi AM, Ryter SW. FLIP inhibits endothelial cell apoptosis during hyperoxia by suppressing Bax. Free Radic Biol Med. 2007;42(10):1599–609.PubMedCrossRef

42.

Laher I, Zhang JH. Protein kinase C and cerebral vasospasm. J Cereb Blood Flow Metab. 2001;21(8):887–906.PubMedCrossRef

43.

Koide M, Nishizawa S, Ohta S, Yokoyama T, Namba H. Chronological changes of the contractile mechanism in prolonged vasospasm after subarachnoid hemorrhage: from protein kinase C to protein tyrosine kinase. Neurosurgery. 2002;51(6):1468–74.PubMed

44.

Tang H, Hao Q, Rutherford SA, Low B, Zhao ZJ. Inactivation of SRC family tyrosine kinases by reactive oxygen species in vivo. J Biol Chem. 2005;280(25):23918–25.PubMedCrossRef

45.

Kusaka G, Kimura H, Kusaka I, Perkins E, Nanda A, Zhang JH. Contribution of Src tyrosine kinase to cerebral vasospasm after subarachnoid hemorrhage. J Neurosurg. 2003;99(2):383–90.PubMedCrossRef

46.

Yamaguchi M, Zhou C, Nanda A, Zhang JH. Ras protein contributes to cerebral vasospasm in a canine double-hemorrhage model. Stroke. 2004;35(7):1750–5.PubMedCrossRef

47.

Yatsushige H, Yamaguchi-Okada M, Zhou C, Calvert JW, Cahill J, Colohan AR, et al. Inhibition of c-Jun N-terminal kinase pathway attenuates cerebral vasospasm after experimental subarachnoid hemorrhage through the suppression of apoptosis. Acta Neurochir Suppl. 2008;104:27–31.PubMedCrossRef

48.

Nosko M, Weir BK, Lunt A, Grace M, Allen P, Mielke B. Effect of clot removal at 24 hours on chronic vasospasm after SAH in the primate model. J Neurosurg. 1987;66(3):416–22.PubMedCrossRef

49.

Crowley RW, Medel R, Kassell NF, Dumont AS. New insights into the causes and therapy of cerebral vasospasm following subarachnoid hemorrhage. Drug Discov Today. 2008;13(5–6):254–60.PubMedCrossRef

50.

Guney O, Erdi F, Esen H, Kiyici A, Kocaogullar Y. N-acetylcysteine prevents vasospasm after subarachnoid hemorrhage. Surg Neurol. 2010;73:42–9.

51.

Munakata A, Ohkuma H, Shimamura N. Effect of a free radical scavenger, edaravone, on free radical reactions: related signal transduction and cerebral vasospasm in the rabbit subarachnoid hemorrhage model. Acta Neurochir Suppl. 2011;110(2):17–22.PubMedCrossRef

52.

Nakamura K, Koga Y, Sakai H, Homma K, Ikebe M. cGMP-dependent relaxation of smooth muscle is coupled with the change in the phosphorylation of myosin phosphatase. Circ Res. 2007;101(7):712–22.PubMedCrossRef

53.

Kehl F, Cambj-Sapunar L, Maier KG, Miyata N, Kametani S, Okamoto H, et al. 20-HETE contributes to the acute fall in cerebral blood flow after subarachnoid hemorrhage in the rat. Am J Physiol Heart Circ Physiol. 2002;282(4):H1556–65.PubMed

54.

Pacher P, Beckman JS, Liaudet L. Nitric oxide and peroxynitrite in health and disease. Physiol Rev. 2007;87(1):315–424.PubMedCrossRef

55.

Ostrowski RP, Tang J, Zhang JH. Hyperbaric oxygen suppresses NADPH oxidase in a rat subarachnoid hemorrhage model. Stroke. 2006;37(5):1314–8.PubMedCrossRef

56.

Kim DE, Suh YS, Lee MS, Kim KY, Lee JH, Lee HS, et al. Vascular NAD(P)H oxidase triggers delayed cerebral vasospasm after subarachnoid hemorrhage in rats. Stroke. 2002;33(11):2687–91.PubMedCrossRef

57.

Zheng JS, Zhan RY, Zheng SS, Zhou YQ, Tong Y, Wan S. Inhibition of NADPH oxidase attenuates vasospasm after experimental subarachnoid hemorrhage in rats. Stroke. 2005;36(5):1059–64.PubMedCrossRef

58.

Matsubara M, Hayashi N, Jing T, Titani K. Regulation of endothelial nitric oxide synthase by protein kinase C. J Biochem. 2003;133(6):773–81.PubMedCrossRef

59.

Hink J, Thom SR, Simonsen U, Rubin I, Jansen E. Vascular reactivity and endothelial NOS activity in rat thoracic aorta during and after hyperbaric oxygen exposure. Am J Physiol Heart Circ Physiol. 2006;291(4):H1988–98.PubMedCrossRef

60.

Elayan IM, Axley MJ, Prasad PV, Ahlers ST, Auker CR. Effect of hyperbaric oxygen treatment on nitric oxide and oxygen free radicals in rat brain. J Neurophysiol. 2000;83(4):2022–9.PubMed

61.

Chavko M, Braisted JC, Outsa NJ, Harabin AL. Role of cerebral blood flow in seizures from hyperbaric oxygen exposure. Brain Res. 1998;791(1–2):75–82.PubMedCrossRef

62.

Toda N, Ayajiki K, Okamura T. Cerebral blood flow regulation by nitric oxide: recent advances. Pharmacol Rev. 2009;61(1):62–97.PubMedCrossRef

63.

Qin Z, Xi G, Keep RF, Silbergleit R, He Y, Hua Y. Hyperbaric oxygen for experimental intracerebral hemorrhage. Acta Neurochir Suppl. 2008;105:113–7.PubMedCrossRef

64.

Zhou C, Yamaguchi M, Kusaka G, Schonholz C, Nanda A, Zhang JH. Caspase inhibitors prevent endothelial apoptosis and cerebral vasospasm in dog model of experimental subarachnoid hemorrhage. J Cereb Blood Flow Metab. 2004;24(4):419–31.PubMedCrossRef

65.

Zubkov AY, Ogihara K, Bernanke DH, Parent AD, Zhang J. Apoptosis of endothelial cells in vessels affected by cerebral vasospasm. Surg Neurol. 2000;53(3):260–6.PubMedCrossRef

66.

Kimura H, Gules I, Meguro T, Zhang JH. Cytotoxicity of cytokines in cerebral microvascular endothelial cell. Brain Res. 2003;990(1–2):148–56.PubMedCrossRef

67.

Iseda K, Ono S, Onoda K, Satoh M, Manabe H, Nishiguchi M, et al. Antivasospastic and antiinflammatory effects of caspase inhibitor in experimental subarachnoid hemorrhage. J Neurosurg. 2007;107(1):128–35.PubMedCrossRef

68.

Zhang Q, Chang Q, Cox RA, Gong X, Gould LJ. Hyperbaric oxygen attenuates apoptosis and decreases inflammation in an ischemic wound model. J Invest Dermatol. 2008;128(8):2102–12.PubMed

69.

Godman CA, Joshi R, Giardina C, Perdrizet G, Hightower LE. Hyperbaric oxygen treatment induces antioxidant gene expression. Ann NY Acad Sci. 2010;1197:178–83.PubMedCrossRef

70.

Tompach PC, Lew D, Stoll JL. Cell response to hyperbaric oxygen treatment. Int J Oral Maxillofac Surg. 1997;26(2):82–6.PubMedCrossRef

71.

Pluta RM. Dysfunction of nitric oxide synthases as a cause and therapeutic target in delayed cerebral vasospasm after SAH. Acta Neurochir Suppl. 2008;104:139–47.PubMedCrossRef

72.

Dumont AS, Dumont RJ, Chow MM, Lin CL, Calisaneller T, Ley KF, et al. Cerebral vasospasm after subarachnoid hemorrhage: putative role of inflammation. Neurosurgery. 2003;53(1):123–33.PubMedCrossRef

73.

Sozen T, Tsuchiyama R, Hasegawa Y, Suzuki H, Jadhav V, Nishizawa S, et al. Role of interleukin-1beta in early brain injury after subarachnoid hemorrhage in mice. Stroke. 2009;40(7):2519–25.PubMedCrossRef

74.

Fassbender K, Hodapp B, Rossol S, Bertsch T, Schmeck J, Schutt S, et al. Endothelin-1 in subarachnoid hemorrhage: an acute-phase reactant produced by cerebrospinal fluid leukocytes. Stroke. 2000;31(12):2971–5.PubMedCrossRef

75.

Takeuchi H, Tanabe M, Okamoto H, Yamazaki M. Effects of thromboxane synthetase inhibitor (RS-5186) on experimentally-induced cerebral vasospasm. Neurol Res. 1999;21(5):513–6.PubMed

76.

Satoh S, Suzuki Y, Harada T, Ikegaki I, Asano T, Shibuya M, et al. The role of platelets in the development of cerebral vasospasm. Brain Res Bull. 1991;27(5):663–8.PubMedCrossRef

77.

Prunell GF, Svendgaard NA, Alkass K, Mathiesen T. Inflammation in the brain after experimental subarachnoid hemorrhage. Neurosurgery. 2005;56(5):1082–92.PubMed

78.

Alex J, Laden G, Cale AR, Bennett S, Flowers K, Madden L, et al. Pretreatment with hyperbaric oxygen and its effect on neuropsychometric dysfunction and systemic inflammatory response after cardiopulmonary bypass: a prospective randomized double-blind trial. J Thorac Cardiovasc Surg. 2005;130(6):1623–30.PubMedCrossRef

79.

Lin CL, Dumont AS, Calisaneller T, Kwan AL, Hwong SL, Lee KS. Monoclonal antibody against E selectin attenuates subarachnoid hemorrhage-induced cerebral vasospasm. Surg Neurol. 2005;64(3):201–5.PubMedCrossRef

80.

Bavbek M, Polin R, Kwan AL, Arthur AS, Kassell NF, Lee KS. Monoclonal antibodies against ICAM-1 and CD18 attenuate cerebral vasospasm after experimental subarachnoid hemorrhage in rabbits. Stroke. 1998;29(9):1930–5.PubMedCrossRef

81.

Polin RS, Bavbek M, Shaffrey ME, Billups K, Bogaev CA, Kassell NF, et al. Detection of soluble E-selectin, ICAM-1, VCAM-1, and L-selectin in the cerebrospinal fluid of patients after subarachnoid hemorrhage. J Neurosurg. 1998;89(4):559–67.PubMedCrossRef

82.

Buras JA, Stahl GL, Svoboda KK, Reenstra WR. Hyperbaric oxygen downregulates ICAM-1 expression induced by hypoxia and hypoglycemia: the role of NOS. Am J Physiol Cell Physiol. 2000;278(2):C292–302.PubMed

83.

Gunther A, Kuppers-Tiedt L, Schneider PM, Kunert I, Berrouschot J, Schneider D, et al. Reduced infarct volume and differential effects on glial cell activation after hyperbaric oxygen treatment in rat permanent focal cerebral ischaemia. Eur J Neurosci. 2005;21(11):3189–94.PubMedCrossRef

84.

Liu JR, Zhao Y, Patzer A, Staak N, Boehm R, Deuschl G, et al. The JNK-inhibitor XG-102 enhances the neuroprotection of hyperbaric oxygen after cerebral ischaemia in adult rats. Neuropathol Appl Neurobiol. 2010;36:211–24.PubMedCrossRef

85.

Cahill J, Calvert JW, Solaroglu I, Zhang JH. Vasospasm and p53-induced apoptosis in an experimental model of subarachnoid hemorrhage. Stroke. 2006;37(7):1868–74.PubMedCrossRef

86.

Kozniewska E, Michalik R, Rafalowska J, Gadamski R, Walski M, Frontczak-Baniewicz M, et al. Mechanisms of vascular dysfunction after subarachnoid hemorrhage. J Physiol Pharmacol. 2006;57 Suppl 11:145–60.PubMed

87.

Grote E, Hassler W. The critical first minutes after subarachnoid hemorrhage. Neurosurgery. 1988;22(4):654–61.PubMedCrossRef

88.

Hoffman WE, Wheeler P, Edelman G, Charbel FT, Torres NJ, Ausman JI. Hypoxic brain tissue following subarachnoid hemorrhage. Anesthesiology. 2000;92(2):442–6.PubMedCrossRef

89.

Hishikawa T, Ono S, Ogawa T, Tokunaga K, Sugiu K, Date I. Effects of deferoxamine-activated hypoxia-inducible factor-1 on the brainstem after subarachnoid hemorrhage in rats. Neurosurgery. 2008;62(1):232–40.PubMedCrossRef

90.

Semenza GL. Regulation of oxygen homeostasis by hypoxia-inducible factor 1. Physiol Bethesda. 2009;24:97–106.CrossRef

91.

Schmidt-Kastner R, Aguirre-Chen C, Kietzmann T, Saul I, Busto R, Ginsberg MD. Nuclear localization of the hypoxia-regulated pro-apoptotic protein BNIP3 after global brain ischemia in the rat hippocampus. Brain Res. 2004;1001(1–2):133–42.PubMedCrossRef

92.

Jeon H, Ai J, Sabri M, Tariq A, Shang X, Chen G, et al. Neurological and neurobehavioral assessment of experimental subarachnoid hemorrhage. BMC Neurosci. 2009;10:103.PubMedCrossRef

93.

Cahill J, Calvert JW, Marcantonio S, Zhang JH. p53 may play an orchestrating role in apoptotic cell death after experimental subarachnoid hemorrhage. Neurosurgery. 2007;60(3):531–45.PubMedCrossRef

94.

Yan J, Chen C, Lei J, Yang L, Wang K, Liu J, et al. 2-Methoxyestradiol reduces cerebral vasospasm after 48 hours of experimental subarachnoid hemorrhage in rats. Exp Neurol. 2006;202(2):348–56.PubMedCrossRef

95.

Yan JH, Yang XM, Chen CH, Hu Q, Zhao J, Shi XZ, et al. Pifithrin-alpha reduces cerebral vasospasm by attenuating apoptosis of endothelial cells in a subarachnoid haemorrhage model of rat. Chin Med J Engl. 2008;121(5):414–9.PubMed

96.

Calvert JW, Cahill J, Yamaguchi-Okada M, Zhang JH. Oxygen treatment after experimental hypoxia–ischemia in neonatal rats alters the expression of HIF-1alpha and its downstream target genes. J Appl Physiol. 2006;101(3):853–65.PubMedCrossRef

97.

Tjarnstrom J, Holmdahl L, Falk P, Falkenberg M, Arnell P, Risberg B. Effects of hyperbaric oxygen on expression of fibrinolytic factors of human endothelium in a simulated ischaemia/reperfusion situation. Scand J Clin Lab Invest. 2001;61(7):539–45.PubMedCrossRef

98.

Sehba FA, Mostafa G, Friedrich Jr V, Bederson JB. Acute microvascular platelet aggregation after subarachnoid hemorrhage. J Neurosurg. 2005;102(6):1094–100.PubMedCrossRef

99.

Padgaonkar VA, Giblin FJ, Fowler K, Leverenz VR, Reddan JR, Dziedzic DC. Heme oxygenase synthesis is induced in cultured lens epithelium by hyperbaric oxygen or puromycin. Exp Eye Res. 1997;65(3):435–43.PubMedCrossRef

100.

Chang KY, Tsai PS, Huang TY, Wang TY, Yang S, Huang CJ. HO-1 mediates the effects of HBO pretreatment against sepsis. J Surg Res. 2006;136(1):143–53.PubMedCrossRef

101.

Pearl JD, Macdonald RL. Vasospasm after aneurysmal subarachnoid hemorrhage: need for further study. Acta Neurochir Suppl. 2008;105:207–10.PubMedCrossRef

102.

Dreier JP, Major S, Manning A, Woitzik J, Drenckhahn C, Steinbrink J, et al. Cortical spreading ischaemia is a novel process involved in ischaemic damage in patients with aneurysmal subarachnoid haemorrhage. Brain. 2009;132(Pt 7):1866–81.PubMedCrossRef

103.

Kleeberg J, Petzold GC, Major S, Dirnagl U, Dreier JP. ET-1 induces cortical spreading depression via activation of the ETA receptor/phospholipase C pathway in vivo. Am J Physiol Heart Circ Physiol. 2004;286(4):H1339–46.PubMedCrossRef

104.

Balestrino M, Young J, Aitken P. Block of (Na⁺,K⁺)ATPase with ouabain induces spreading depression-like depolarization in hippocampal slices. Brain Res. 1999;838(1–2):37–44.PubMedCrossRef

105.

Yufu K, Itoh T, Edamatsu R, Mori A, Hirakawa M. Effect of hyperbaric oxygenation on the Na⁺, K(+)-ATPase and membrane fluidity of cerebrocortical membranes after experimental subarachnoid hemorrhage. Neurochem Res. 1993;18(9):1033–9.PubMedCrossRef

106.

Titova E, Ostrowski RP, Zhang JH, Tang J. Experimental models of subarachnoid hemorrhage for studies of cerebral vasospasm. Neurol Res. 2009;31(6):568–81.PubMedCrossRef

107.

Li Y, Zhou C, Calvert JW, Colohan AR, Zhang JH. Multiple effects of hyperbaric oxygen on the expression of HIF-1 alpha and apoptotic genes in a global ischemia–hypotension rat model. Exp Neurol. 2005;191(1):198–210.PubMedCrossRef

108.

Gu GJ, Li YP, Peng ZY, Xu JJ, Kang ZM, Xu WG, et al. Mechanism of ischemic tolerance induced by hyperbaric oxygen preconditioning involves upregulation of hypoxia-inducible factor-1alpha and erythropoietin in rats. J Appl Physiol. 2008;104(4):1185–91.PubMedCrossRef

109.

Cash TP, Pan Y, Simon MC. Reactive oxygen species and cellular oxygen sensing. Free Radic Biol Med. 2007;43(9):1219–25.PubMedCrossRef

110.

Jones NM, Lee EM, Brown TG, Jarrott B, Beart PM. Hypoxic preconditioning produces differential expression of hypoxia-inducible factor-1alpha (HIF-1alpha) and its regulatory enzyme HIF prolyl hydroxylase 2 in neonatal rat brain. Neurosci Lett. 2006;404(1–2):72–7.PubMedCrossRef

111.

Chen W, Ostrowski RP, Obenaus A, Zhang JH. Prodeath or prosurvival: two facets of hypoxia inducible factor-1 in perinatal brain injury. Exp Neurol. 2009;216(1):7–15.PubMedCrossRef

112.

Halterman MW, Miller CC, Federoff HJ. Hypoxia-inducible factor-1alpha mediates hypoxia-induced delayed neuronal death that involves p53. J Neurosci. 1999;19(16):6818–24.PubMed

113.

Grasso G. An overview of new pharmacological treatments for cerebrovascular dysfunction after experimental subarachnoid hemorrhage. Brain Res Brain Res Rev. 2004;44(1):49–63.PubMedCrossRef

114.

Jahromi BS, Aihara Y, Ai J, Zhang ZD, Nikitina E, Macdonald RL. Voltage-gated K⁺ channel dysfunction in myocytes from a dog model of subarachnoid hemorrhage. J Cereb Blood Flow Metab. 2008;28(4):797–811.PubMedCrossRef

115.

Sobey CG. Cerebrovascular dysfunction after subarachnoid haemorrhage: novel mechanisms and directions for therapy. Clin Exp Pharmacol Physiol. 2001;28(11):926–9.PubMedCrossRef

116.

Ishiguro M, Morielli AD, Zvarova K, Tranmer BI, Penar PL, Wellman GC. Oxyhemoglobin-induced suppression of voltage-dependent K⁺ channels in cerebral arteries by enhanced tyrosine kinase activity. Circ Res. 2006;99(11):1252–60.PubMedCrossRef

117.

Jahromi BS, Aihara Y, Ai J, Zhang ZD, Weyer G, Nikitina E, et al. Temporal profile of potassium channel dysfunction in cerebrovascular smooth muscle after experimental subarachnoid haemorrhage. Neurosci Lett. 2008;440(1):81–6.PubMedCrossRef

118.

Lou M, Chen Y, Ding M, Eschenfelder CC, Deuschl G. Involvement of the mitochondrial ATP-sensitive potassium channel in the neuroprotective effect of hyperbaric oxygenation after cerebral ischemia. Brain Res Bull. 2006;69(2):109–16.PubMedCrossRef

119.

Colantuono G, Tiravanti EA, Di Venosa N, Cazzato A, Rastaldo R, Cagiano R, et al. Hyperoxia confers myocardial protection in mechanically ventilated rats through the generation of free radicals and opening of mitochondrial ATP-sensitive potassium channels. Clin Exp Pharmacol Physiol. 2008;35(1):64–71.PubMedCrossRef

120.

Parekh AB, Putney Jr JW. Store-operated calcium channels. Physiol Rev. 2005;85(2):757–810.PubMedCrossRef

121.

Zuccarello M, Boccaletti R, Tosun M, Rapoport RM. Role of extracellular Ca²⁺ in subarachnoid hemorrhage-induced spasm of the rabbit basilar artery. Stroke. 1996;27(10):1896–902.PubMedCrossRef

122.

Veltkamp R, Bieber K, Wagner S, Beynon C, Siebing DA, Veltkamp C, et al. Hyperbaric oxygen reduces basal lamina degradation after transient focal cerebral ischemia in rats. Brain Res. 2006;1076(1):231–7.PubMedCrossRef

123.

McGirt MJ, Lynch JR, Blessing R, Warner DS, Friedman AH, Laskowitz DT. Serum von Willebrand factor, matrix metalloproteinase-9, and vascular endothelial growth factor levels predict the onset of cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Neurosurgery. 2002;51(5):1128–34.PubMedCrossRef

124.

Ostrowski RP, Jadhav V, Chen W, Zhang JH. Reduced matrix metalloproteinase-9 activity and cell death after global ischemia in the brain preconditioned with hyperbaric oxygen. Acta Neurochir Suppl. 2010;106:47–9.PubMedCrossRef

125.

Dirnagl U, Becker K, Meisel A. Preconditioning and tolerance against cerebral ischaemia: from experimental strategies to clinical use. Lancet Neurol. 2009;8(4):398–412.PubMedCrossRef

126.

Keep RF, Wang MM, Xiang J, Hua Y, Xi G. Is there a place for cerebral preconditioning in the clinic? Transl Stroke Res. 2010;1(1):4–18.PubMedCrossRef

127.

Gidday JM. Pharmacologic preconditioning: translating the promise. Transl Stroke Res. 2010;1(1):19–30.PubMedCrossRef

128.

Kunz A, Park L, Abe T, Gallo EF, Anrather J, Zhou P, et al. Neurovascular protection by ischemic tolerance: role of nitric oxide and reactive oxygen species. J Neurosci. 2007;27(27):7083–93.PubMedCrossRef

129.

Godman CA, Chheda KP, Hightower LE, Perdrizet G, Shin DG, Giardina C. Hyperbaric oxygen induces a cytoprotective and angiogenic response in human microvascular endothelial cells. Cell Stress Chaperones. 2010;15:431–42.PubMedCrossRef

130.

Lee CC, Chen SC, Tsai SC, Wang BW, Liu YC, Lee HM, et al. Hyperbaric oxygen induces VEGF expression through ERK, JNK and c-Jun/AP-1 activation in human umbilical vein endothelial cells. J Biomed Sci. 2006;13(1):143–56.PubMedCrossRef

131.

Sato H, Bolli R, Rokosh GD, Bi Q, Dai S, Shirk G, et al. The cardioprotection of the late phase of ischemic preconditioning is enhanced by postconditioning via a COX-2-mediated mechanism in conscious rats. Am J Physiol Heart Circ Physiol. 2007;293(4):H2557–64.PubMedCrossRef

132.

Zhang N, Gao G, Bu X, Han S, Fang L, Li J. Neuron-specific phosphorylation of c-Jun N-terminal kinase increased in the brain of hypoxic preconditioned mice. Neurosci Lett. 2007;423(3):219–24.PubMedCrossRef

133.

Granziera C, Thevenet J, Price M, Wiegler K, Magistretti PJ, Badaut J, et al. Thrombin-induced ischemic tolerance is prevented by inhibiting c-Jun N-terminal kinase. Brain Res. 2007;1148:217–25.PubMedCrossRef

Titel: Hyperbaric Oxygen for Cerebral Vasospasm and Brain Injury Following Subarachnoid Hemorrhage
verfasst von: Robert P. Ostrowski
John H. Zhang
Publikationsdatum: 01.09.2011
Verlag: Springer-Verlag
Erschienen in: Translational Stroke Research / Ausgabe 3/2011
Print ISSN: 1868-4483
Elektronische ISSN: 1868-601X
DOI: https://doi.org/10.1007/s12975-011-0069-1

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Neurologie

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders gilt das offenbar für weibliche Kranke, wie eine Studie zeigt.

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2011

The Cardiovascular Triad of Dysfunctional Angiogenesis

Low-Power 2-MHz Pulsed-Wave Transcranial Ultrasound Reduces Ischemic Brain Damage in Rats

Expression of Histone Deacetylases in Cellular Compartments of the Mouse Brain and the Effects of Ischemia

Biological Features of Human Bone Marrow Stromal Cells (hBMSC) Cultured with Animal Protein-Free Medium—Safety and Efficacy of Clinical Use for Neurotransplantation

Recombinant T Cell Receptor Ligands Improve Outcome After Experimental Cerebral Ischemia